Srs Capital Advisors, Inc. Spdr Ser Tr Spdr S&P Biotech E Transaction History
Srs Capital Advisors, Inc.
- $1.5 Billion
- Q4 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 300 shares of XBI stock, worth $27,372. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300
Previous 225
33.33%
Holding current value
$27,372
Previous $22,000
22.73%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding XBI
# of Institutions
918Shares Held
96.6MCall Options Held
29.6MPut Options Held
33.6M-
Jpmorgan Chase & CO New York, NY12.3MShares$1.12 Billion0.1% of portfolio
-
Goldman Sachs Group Inc New York, NY9.56MShares$872 Million0.14% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A69.23MShares$842 Million2.24% of portfolio
-
Morgan Stanley New York, NY8.02MShares$732 Million0.06% of portfolio
-
Citigroup Inc7.75MShares$707 Million0.45% of portfolio